Insulin in Type 2 Diabetes

Slides:



Advertisements
Similar presentations
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Advertisements

Diabetes Care Tasks at School: What Key Personnel Need to Know Diabetes Care Tasks at School: What Key Personnel Need to Know INSULIN ADMINISTRATION.

Diabetes (abridged!). Who needs screening for DM? Age >45 Obese – BMI >25 1 st degree relative with DM Racial groups: –African American –Hispanic American.
Text insulin Management in type 2 diabetes mellitus PRACTICAL POINTERS FOR CLINICAL PRACTICE.
Insulin Diabetes Outreach (June 2011). 2 Insulin Learning outcomes >Understand the difference between insulin therapy in type 1 diabetes as compared to.
Management of Diabetes Mellitus in the Hospital
Dr. A. R. GOHARIAN Endocrinologist
PTCE Handout 7: Diabetes
Insulin therapy.
PRACTICAL INSULIN USE PRACTICAL INSULIN USE or, how to think like a pancreas Oliver Z. Graham, MD Department of Internal Medicine Virtual Endocrinologist.
Basal-Bolus, Insulin Pumps, Carbohydrate Counting, Combination Therapy Dr.Ihab Tadros Medical Director Daisy Care Medical – USA The Leader in insulin Pump.
Kathryn A. Hanavan ANP-BC; BC-ADM Harold Schnitzer Diabetes Health Center September 12,
INSULIN THERAPY IN TYPE 1 DIABETES
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Titrating Insulin to Glycemic Target Judy Bowen, MD CIM Rotation September, 2006.
Basal and Meal Time Insulin Case Study
OnsetPeakDuration Rapid Acting Lispro (Humalog) min3-5 hours Aspart (Novolog)15-30 min1-3 hours3-5 hours Intermediate Acting NPH1-4 hours5-10.
Inpatient Glycemic Management
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 3 of 3.
New Insulin Formulations
DIABETES MELLITUS THOMAS MILLIGAN, DO OSU-COM FAMILY MEDICINE.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Toujeo® and it’s Place in Therapy
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 2.
Insulins Roland Halil, BScPharm, ACPR, PharmD Clinical Pharmacist, Bruyere Academic Family Health Team Assistant Professor, Dept of Family Medicine, U.
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
What Key Personal Need To Know INSULIN ADMINISTRATION.
Insulin Therapy-What’s New
Diabetes Mellitus Part 2 Kathy Martin DNP, RN, CNE.
Special Situations In The Management Of In-Patient Hyperglycemia
INITIATION OF INSULIN THERAPY DR OKUNOWO EDM UNIT.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS.
Quality of Life Matters NOT TOO HIGH… NOT TOO LOW… A PLAN FOR OPTIMIZING DIABETES MANAGEMENT IN NURSING HOMES 5. Insulin: Part 1.
New Subcutaneous Insulin Protocol for Type 2 Diabetics
Representative insulin regimens for the treatment of diabetes
Medications Used in the Treatment of Diabetes Mellitus
Small concise points on Insulin
Insulins Roland Halil, BScPharm, ACPR, PharmD
Insulin Initiation and Titration
Insulin Type (trade name)
Inpatient Glycemic Management
Representative insulin regimens for the treatment of diabetes
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
Tips and Tools for Managing Diabetes
Representative insulin regimens for the treatment of diabetes
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS
Blood Glucose Measurement And Insulin Administration
Representative insulin regimens for the treatment of diabetes
Insulins Roland Halil, BScPharm, ACPR, PharmD
Representative insulin regimens for the treatment of diabetes
Representative insulin regimens for the treatment of diabetes
First step into insulin therapy
Insulins Roland Halil, BScPharm, ACPR, PharmD
Comparison of Basal insulins, Initiation and titration of Lantus
Karen McAvoy RN, MSN, CDE Joslin Diabetes Center
Drugs for Diabetes Mellitus
Diabetes Jessica Tagerman PharmD
Insulin Safety know your insulins! There are many! Humalog® Mix25 Humalog® Mix50 Humulin® I Humulin® M3 Humulin® S Humalog® U-100 Humalog® U-200.
T1DM: Insulin Initiation
Blood Glucose Measurement And Insulin Administration
Sequential insulin strategies in type 2 diabetes.
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Approach to starting and adjusting insulin in type 2 diabetes.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Inpatient Insulin Management on the Wards
CPPE Optimise: Insulins
Hyperglycemic Targets & Hypoglycemia
Presentation transcript:

Insulin in Type 2 Diabetes Shamili Allam, PGY3 8/1/19

Physiologic Insulin Release https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/913b0ba7a16aeb239733dd205283ef1b6f89387d/2-Figure1-1.png

Insulin formulations Insulin Onset Peak Duration Lispro 3-15 min 2-4 hours Regular 30 min 5-8 hours NPH 2 hours 4-12 hours ~12 hours Glargine None 20-24 hours https://www.diabetes.co.uk/forum/threads/changing-insulin-to-nph.109906/ https://www.uptodate.com/contents/image?imageKey=ENDO%2F73676&topicKey=ENDO%2F1752&source=see_link

Glargine-Lispro Total daily dose 1/2 glargine 1/2 lispro 1/3 breakfast 1/3 dinner 1/3 lunch Fingerstick Glucose Insulin to adjust Pre-breakfast Glargine Pre-lunch Breakfast lispro Pre-dinner Lunch lispro Nighttime Dinner lispro

NPH-Regular Total daily dose 2/3 AM 1/3 PM 2/3 AM NPH 1/3 AM regular 1/2 PM NPH 1/2 PM regular Fingerstick Glucose Insulin to adjust Pre-breakfast PM NPH Pre-lunch AM Regular + AM NPH Pre-dinner AM NPH Nighttime PM Regular + PM NPH

Novolin 70/30 Total daily dose 2/3 AM 1/3 PM Fingerstick Glucose Insulin to adjust Pre-breakfast PM Pre-lunch AM Pre-dinner Nighttime

When to initiate insulin Poorly controlled DM on diagnosis HgA1c > 10% FS > 300 Symptomatic hyperglycemia Weight loss Polyuria Polydipsia After failing oral agents

How to initiate Insulin Consider starting basal insulin first Glargine 10U, or 0.1-0.2 U/kg Titrate up to FS target If FS at goal but HbA1c is not, or using 0.7-1.0 U/kg basal: Stepwise initiation of prandial insulin Can start with 1 meal first (biggest meal first) Eventually will need full basal-prandial regimen Discontinue: Sulfonylureas Pioglitazone

Blood sugar Goals Most patients: HbA1c < 7% Average blood glucose < 154 mg/dL Fasting sugars 80-130 mg/dL Post-prandial (1-2h after meal) < 180 mg/dL Lenient control (h/o hypoglycemia, limited life expectancy) HbA1c < 8% Average blood glucose < 183 mg/dL Fasting sugars 100-140 mg/dL Post-prandial (1-2h after meal) < 200 mg/dL Different goals are appropriate for different patients http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/checking-your-blood-glucose.html

How to prescribe insulin Each pen = 3mL = 300 units

How to prescribe Insulin clear cloudy Each vial = 10mL = 1000 units

How to prescribe Insulin

Practical Considerations When to inject Glargine: bedtime, but can switch to qAM (to avoid early morning lows) Lispro: ~10 min before meals NPH/Regular: ~30 min before breakfast & dinner How to store insulin All unopened insulin should be stored in the fridge Vials (NPH, regular, 70/30) can be kept at room temp (< 77F) for 6 weeks Pens (Basaglar, Humalog) can be kept at room temp (<86F) for 4 weeks Accuracy Pens are more accurate for small doses (< 5 units) Hypoglycemic education Always carry 15g of carbs (4 oz of juice, small apple) Consider prescribing glucagon Medical bracelet

How to inject Insulin Rotate injection sites Mixing Syringes: Pens Draw up regular insulin before drawing up NPH in the syringe (“clear before cloudy”) Syringes: Pinch a fold of skin Inject at 90 degrees Pens Keep thumb on plunger for 5 seconds https://www.uptodate.com/contents/images/PC/78710/Insulin_injection_sites.jpg

MkSAP Question A 64-year-old man with type 2 diabetes mellitus and stage 4 chronic kidney disease is evaluated for continued glycemic management. He is followed closely by the nephrology service in preparation for impending hemodialysis, with initiation of erythropoietin therapy within the last 3 months. His average fasting and preprandial blood glucose values are in the 145 to 190 mg/dL (8.0 – 10.5 mmol/L) range. He does not have hypoglycemia. His insulin regimen consists of insulin detemir at bedtime and insulin glulisine before meals. His most recent hemoglobin A1c value has decreased from 7.5% to 6.2% Which of the following is the most appropriate management for this patient’s diabetes? A. Continue current therapy B. Decrease insulin detemir dose C. Discontinue preprandial insulin glulisine D. Measure postprandial glucose level

References https://clinical.diabetesjournals.org/content/37/1/11 https://care.diabetesjournals.org/content/27/suppl_1/s106 https://www.uptodate.com/contents/general-principles-of-insulin-therapy-in- diabetes-mellitus?source=history_widget